Table 3.
Male | Female | P-value | |
---|---|---|---|
Animal number | 4 | 5 | |
BUN (mg/dl) | 36.3 ± 1.3 | 31.7 ± 1.9 | <0.01 |
Cr (mg/dl) | 0.34 ± 0.09 | 0.31 ± 0.07 | <0.05 |
CrCl (ml/min/100g BW) | 0.69 ± 0.04 | 0.77 ± 0.06 | <0.05 |
Plasma Pi (mg/dl) | 8.21 ± 0.32 | 7.62 ± 0.24 | <0.05 |
Plasma Ca (mg/dl) | 9.21 ± 0.10 | 9.11 ± 0.07 | >0.05 |
Plasma PTH (pg/ml) | 321 ± 52 | 291 ± 42 | >0.05 |
Plasma 1,25-(OH)2D3 (pg/ml) | 70.4 ± 6.2 | 65.5 ± 5.3 | >0.05 |
Plasma FGF23 (pg/ml) | 2016 ± 330 | 1757 ± 139 | >0.05 |
Heart weight/body weight (mg/g) | 5.69 ± 0.32 | 5.28 ± 0.31 | 0.08 |
Data presented in Table 3 are derived from mice injected cisplatin and treated with normal Pi diet presented in Table 2 and were shown as means ± SD at 20 weeks. The statistical significance between male and female mice was analyzed by unpaired Student t-test